Pfizer Inc. has voluntarily recalled approximately 26,691 bottles of Accuretic (quinapril HCl/hydrochlorothiazide) and generic quinapril and hydrochlorothiazide tablets. These blood pressure medications are being recalled because they contain nitrosamine impurities at levels higher than the acceptable daily intake limit set by health authorities. No incidents or injuries have been reported to date. These prescription medications were manufactured in Germany and distributed to pharmacies across the United States.
The medications contain impurities called N-nitroso-quinapril and N-nitroso-hydrochlorothiazide. These nitrosamines are common in water and foods but may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.
You have 2 options:
Recall #: D-0756-2022
Recall #: D-0757-2022
Recall #: D-0758-2022
Recall #: D-0759-2022
Recall #: D-0760-2022
Recall #: D-0761-2022
Recall #: D-0754-2022
Recall #: D-0755-2022
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.